quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:50:58·23d
SECFiling
Charles River Laboratories International Inc. logo

SEC Form DEF 14A filed by Charles River Laboratories International Inc.

CRL· Charles River Laboratories International Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • CRL
    Charles River Laboratories International Inc.
    Health Care

Recent analyst ratings

  • Apr 14UpdateRBC Capital Mkts$215.00
  • Dec 15UpdateBofA Securities$225.00
  • Nov 17UpdateArgus-
  • Nov 6UpdateRobert W. Baird$199.00
  • Oct 6UpdateWilliam Blair-
  • Oct 2UpdateBarclays$195.00

Related

  • PR2d
    Charles River Highlights Effectiveness of VCGs in Toxicology
  • PR7d
    Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call
  • ANALYST9d
    RBC Capital Mkts initiated coverage on Charles River with a new price target
  • PR14d
    Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
  • INSIDER15d
    SEC Form 3 filed by new insider Coleman Glenn
  • PR17d
    NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Charles River Laboratories International Inc.
  • INSIDER49d
    Corporate Executive VP & COO Girshick Birgit gifted 328 shares (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022